Proud to support @bigxresearch.bsky.social Pink October webinar on 22 Oct! A vital dialogue on climate change & breast cancer research. Let’s rethink trials for a healthier planet & better outcomes. 🔗All the information here: eortc.org/event/bigs-a... bigagainstbreastcancer.org/events/big-p...

📢 Today, at the NASEM National Cancer Policy Forum, our colleague Claire Piccinin will present perspectives from EORTC on patient-centred initiatives and ongoing efforts to promote the impactful use of patient-reported outcome data 👇 www.nationalacademies.org/event/44567_... #QLG @qol.eortc.org

LIVE from @europarl.europa.eu. EORTC, MEPs Metz & Jerkovic call for treatment optimisation through independent research. 📢EORTC & @cancerpatientseu.bsky.social launched a White Paper at this event urging broad support to improve Europe’s health outcomes. Read more: www.eortc.org/blog/2025/09...

On #WorldCancerResearchDay, #EORTC stands for independent clinical research that puts patients first. Too many face avoidable toxicity from high-dose cancer drugs. We’re rethinking what “effective” means: right dose, right duration, right outcome. #WCRD #CancerResearch #ClinicalResearch

The DREAM trial (first EORTC-JCOG intergroup study) is now published in JAMA Surgery! Made possible by the EORTC Fellowship, this global academic partnership shows how collaboration drives impactful cancer research. 🔗 jamanetwork.com/journals/jam... #DREAMTrial #GlobalOncology

Yesterday was World Radiotherapy Awareness Day. A day to reflect on radiotherapy’s impact. Take a look at a recent study on how tumour irradiation can trigger immunogenic responses. Radiotherapy is evolving beyond local control. 🔗 Read more: doi.org/10.1016/j.ra... #RTQA

The Boots Group & EORTC support World Radiotherapy Awareness Day. Mrs. Ornella Barra, CEO of Boots, shares why radiotherapy matters & why access must be equal. EORTC’s E²-RADIatE is Europe’s only radiation oncology platform driving innovation with real-world data. studio.youtube.com/video/CcyY-6...

🔔 New in @thelancetoncol.bsky.social: Policy review led by Ian Tannock & Madeline Pe with EORTC & CSO highlights the critical role of patient quality of life data in the evaluation of treatments for people with advanced cancer. 📖Read more: www.eortc.org/blog/2025/09... #CancerResearch #QualityofLife

📢 EORTC is hiring a full-time Events and Communications Assistant! Support international meetings & contribute to impactful communications. Are you organised, detail-oriented & passionate about events? 👉 Apply now: www.eortc.org/job/events-c... #EventsJobs #EORTC #CancerResearch

A call for equity in cancer care from HRH Princess Dina. Radiotherapy is vital for 1 in 2 cancer patients, yet access remains unequal. As EORTC-ECRF Honorary President, she supports research and innovation to change that. 🎥 Watch her message ahead of #WRAD on Sept 7: www.youtube.com/watch?v=PzKv...

📢 Virginia Delucchi presented her poster at #ISCB46 in Basel! Her study reviewed 500+ RCTs of solid tumours and found that while discontinuation is widely reported, post-treatment data often isn’t. Potentially leading to misinterpretation of treatment effects. #CancerCare #ClinicalTrials

🎯 New date! Join EORTC on 24 Sept 2025 for Treatment Optimisation: Making Cancer Treatment Accessible & Sustainable in Europe, hosted by Mrs Tilly Metz at the @europarl.europa.eu. 🗓️ 24 Sept 📍 EU Parliament & online 🔗 www.eortc.org/event/eortc-... ⚠️ Previous registrations are invalid.

Registration closes tomorrow! Join us at EORTC Patient Days – 2 days dedicated to cancer patients, caregivers & advocates. 📅 6–7 November, Brussels ⏳ Apply by tomorrow: www.eortc.org/patient-days #EORTCPatientDays #PatientAdvocacy

📰New @uiccofficial.bsky.social International Journal of Cancer study by K. Taylor et al. for @qol.eortc.org & @eortc.org Head & Neck Cancer (HNC) Group: 68% of long-term HNC survivors face moderate–severe toxicities. Insights can guide patient info & survivorship care. doi.org/10.1002/ijc.... #QoL

🚨 New publication! The #LUMEN1 trial protocol is out in @journalofnucmed.bsky.social. This is the 1st randomised trial of [¹⁷⁷Lu]Lu-DOTATATE for recurrent #meningioma, exploring SSTR2-targeted therapy + advanced imaging, profiling & AI. 🔗 www.eortc.org/bibliography/ #EORTCBrain #NeuroOncology

🧬 Passionate about patient involvement in cancer research? Join us at EORTC Patient Days, where patients, researchers & advocates connect. 📅 6–7 November, Brussels 👉 Apply by 15 Aug: www.eortc.org/patient-days #EORTCPatientDays #PatientAdvocacy

Are cancer treatments truly optimised for patients? Our CEO, Denis Lacombe, shares why treatment optimisation must be central to cancer care, and how EU policy can help. 🔗 europeancancer.org/resources/ne... #CancerCare #TreatmentOptimisation

First patient enrolled in the EORTC-2148 #MRDproject! This trial explores if a blood test can detect cancer recurrence earlier than scans, a major step in personalised care. 🔗 www.eortc.org/blog/2025/08... @guardanthealth.bsky.social Ligue contre le cancer #EORTCheadandneck #EORTCmelanoma

🌍 EORTC Patient Days 2025 6-7 November, Brussels 🧬 Empowering patients through knowledge & connection. Hear from our colleague Iryna on why you shouldn't miss it! #EORTCPatientDays #CancerResearch #PatientAdvocacy

📢 Registration is now open for EBCC-15! 📍 Barcelona | 25–27 March 2026 Join us in shaping the future of multidisciplinary breast cancer care event.eortc.org/ebcc15/indiv... #EBCC15 #BreastCancer #Oncology #BCSM @oncoalert.bsky.social @europadonna.bsky.social

📢 EORTC is hiring a Statistical Analyst! Use your #SAS expertise to support international cancer clinical trials & data reporting in a multidisciplinary environment. Apply now 👉 www.eortc.org/job/statisti... #Jobs #WorkWithUs #CancerResearch

📢New publication alert! Results from the EORTC-1560-GITCG (ILOC) phase II trial are now in #ESMOOpen. The study assessed local ablative therapy + #immunotherapy in unresectable liver metastases from #colorectalcancer. 🔗Read more: www.eortc.org/bibliography/ #CancerResearch #EORTCgastrointestinal

📢 Don’t miss next week’s webinar! Join the EORTC Lung Cancer & PAMM Groups on 22 July to explore how pharmacological interactions impact thoracic oncology treatment. 🔗 Register now: eortc.wufoo.com/forms/z1ov02... #EORTClung #EORTCpamm #OncologyWebinar #Pharmacology #LungCancer

🧠New publication from the EORTC-BTG-1320 trial: Discover how advanced imaging metrics could improve prognostic accuracy in neuro-oncology. 👇 🔗 Read more: www.eortc.org/bibliography/ #NeuroOncology #Meningioma #EORTCbrain #CancerResearch

🚨 Fellowship opportunity at EORTC! Passionate about patient-centred research in oncology? Join EORTC’s #QualityofLife team in Brussels for hands-on experience in designing, managing & analysing QoL studies in cancer trials. Apply now 👉 www.eortc.org/job/fellowsh... @qol.eortc.org #CancerResearch

🫁 Why do some treatments fail to produce a response in patients, while others cause severe toxicity? Join the EORTC LCG webinar to explore how pharmacological interactions shape outcomes in thoracic oncology 🎙️ Keynote speaker: Dr Veerman 🔗 Register: eortc.wufoo.com/forms/z1ov02... #EORTCLungCancer

🎉 We’re excited to announce that the first patient has been randomised in the PROLoNG study! 👉 www.eortc.org/research_fie... #CancerResearch #ClinicalTrials #Oncology #HeadandNeckCancer #EORTCheadandneck

📢 At #ESMOGI25 today: EORTC hosts a special session with 5 expert lectures + Q&A on neoadjuvant advances, organ preservation & novel targets in GI oncology (16:30–18:00, Room Valencia). Also: 2 poster displays from 15:30–16:30 (Foyer). @myesmo.bsky.social #EORTCgastrointestinal #GIOncology

🎤“#EUHTA's regulation offers a framework for collaborative assessment, potentially speeding up patient access to new treatments. But it overlooks treatment optimisation & post-licensing studies. Balanced systems are key to patient-centricity,” Denis Lacombe at EU HTA conference.

📍We are in Barcelona for #ESMOGI25. Come and visit us at our booth #25. Don't miss EORTC's special session and poster displays tomorrow. Stay tuned! 👉More info: www.eortc.org/app/uploads/... @myesmo.bsky.social #EORTCgastrointestinal #ClinicalTrials #CancerResearch #GastroIntestinalCancer

🧠 New EORTC survey shows PET imaging is widely available and used across European brain tumour centres. With data from 103 centres in 20 countries, the findings support PET-based endpoints in future trials. 🔗 Find out more: www.eortc.org/blog/2025/07... #EORTCbrain #PETImaging

🎯 Join us for an EORTC event at the European Parliament hosted by Mrs R. Jerkovic about treatment optimisation: Making Cancer Treatment Accessible & Sustainable in Europe. 📅 25 September 2025 📍 Brussels & Online 👉 www.eortc.org/event/eortc-... #CancerResearch #ClinicalTrials

📢 Join us! The EORTC Clinical Operations Department is seeking two Junior Clinical Operations Managers to strengthen its team at our HQ in #Brussels. Apply now: www.eortc.org/job/junior-c... #ClinicalOperationsManager #Healthcare #Vacancy #WorkWithUs #Jobs #CancerResearch

📢Excited to announce @benjaminbessemd.bsky.social as EORTC President-Elect, starting in June 2026, following @winettevandergraaf.bsky.social 🙌 Also, we welcome the new chairs of the Scientific Chairs Council: Anne-Marie Dingemans and Jean-Pascal Machiels!🔬🎉 👉 www.eortc.org/blog/2025/06...

📅 Get ready to make the most of EORTC’s upcoming events! Mark your calendars 👇 #CancerResearch #ClinicalTrials #Oncology #EORTCevents #PatientDays #EBCC15 #Stats2026 #MCCRworkshop #ENASymp26

📢 Team of international researchers establish @eortc.org QLQ-F17 as an equivalent to EORTC QLQ-C30 to assess functioning in cancer patients. 👉 Learn more about this recent study in the related news release just published: qol.eortc.org/researchers-... #QualityofLife @mogensgroenvold.bsky.social

🧬 New in The Lancet Oncology The EORTC-1612 EBIN trial results are out, comparing 2 strategies for advanced melanoma & addressing a key question: Should targeted therapy or immunotherapy come first for BRAF V600E/K mutations? 🔗 www.eortc.org/bibliography/ @thelancetoncol.bsky.social #EORTCmelanoma

⏳ Registrations are open until 16:00 CEST today for the Joint webinar Competing risk in older cancer patients. 👉 cm.eortc.org/cmPortal/Por...

#MCCRWorkshop Faculty & Fellows, class of 2025! Since 1999, this workshop has fostered innovation, collaboration, and groundbreaking research in clinical cancer. #EORTC @myesmo.bsky.social @theaacr.bsky.social

🚨 EORTC is hiring a fellow to help shape the future of #PROMs in cancer trials! Join our Brussels HQ for a 1-year (renewable) Fellowship in Quality of Life Research (RP-2243) and align PROMs with evolving clinical standards. 🔗 Apply: www.eortc.org/job/fellowsh... #CancerResearch #QualityOfLife

🎉 Today was the final day of the EORTC Clinical Trial Statistics for Non-Statisticians course #STATS2025 A huge thank you to our speakers, participants, and organisers for making this event a success! 🙌 #CancerResearch #ClinicalTrials #StatisticalMethods #ClinicalResearch #StatisticsForResearch

📣 Heading to #EHA2025? Don’t miss Sophie Teesink’s oral presentation on biomarker insights from the EORTC-1537-COBRA trial in advanced-stage Hodgkin lymphoma! 🗓 Today at 18:00 CEST |📍 Room: Coral 4+5 #EORTClymphoma #Lymphoma #ClinicalResearch #Haematology

🌟 Kicking off the first official day of #STATS2025🌟 🔍 Over the next few days our participants will acquire a greater understanding of the statistical principles whilst avoiding too technical formulations #CancerResearch #ClinicalTrials #StatisticalMethods #ClinicalResearch #StatisticsForResearch

🎗️🩺We are delighted to announce the official start of the @horizoneu.bsky.social funded DE-ESCALATE #ClinicalTrial on metastatic #prostatecancer, in collaboration with Syreon Research Institute. More: www.eortc.org/blog/2025/06... @ec.europa.eu #DEESCALATE_Horizon #HorizonEurope #MensHealthWeek

🆕 The EORTC 2024 Annual Report is out now! We are proud to share a year of progress in independent, patient-centred #CancerResearch, powered by collaboration and innovation. Explore our highlights, new scientific strategy, and vision for the future. 🔗 www.eortc.org/blog/2025/06... #Oncology

What an incredible experience to take part in this year’s ASCO Congress! Congratulations to all the EORTC members who represented us at this prestigious event.👨‍⚕️ Learn more: www.eortc.org/blog/2025/06... @ascocancer.bsky.social #CancerResearch #Oncology #ASCO25

We’re pleased to announce that Jordan has officially joined the #OligoRARE study with the activation of King Hussein Cancer Foundation and Center. This marks the first trial initiated under the EORTC Middle East Coordination Office (MECO) agreement.🌍 @komoptegenkanker.bsky.social

📢 Join us for the EORTC Older Adult Council #webinar on competing risks in frail patients, in collaboration with the EORTC HNCG and GUCG. 📅19 June 2025 ⏰17:00 – 18:15 CEST 📍Virtual event 🔗 Register now: www.eortc.org/event/compet... #CancerResearch #ClinicalTrials #Oncology

📢 Delighted to share a new publication in Annals of Oncology. PEACE III is the first major Phase III trial to combine an ARPI with radiopharmaceutical that showed statistical significance in meeting the primary endpoint.https://ow.ly/SH8K50W1Zct @silkegillessen.bsky.social

🎉We’re proud to share that the RP-2011 #ReCare cohort of the #E2RADIatE platform reached a major milestone: its 500th patient enrolled since launching in May 2023. This marks the successful completion of the first phase of recruitment. Learn more: project.eortc.org/e2-radiate/2...